Why the study?
Is exosomal miR-34a associated with markers of dyslipidemia and endothelial dysfunction in children and adolescents with T1DM?
Is exosomal miR-34a associated with markers of dyslipidemia and endothelial dysfunction in children and adolescents with T1DM?
Exosomal miR-34a may play a role in regulating lipid metabolism and endothelial function in pediatric patients with type 1 diabetes.
Answers are grounded in this paper and cite their sources.
Exosomal miR-34a merits prospective validation as biomarker in pediatric T1DM; hypothesis-generating and should not yet change practice.
This was the first study to show the altered expression of exosomal miR-34a among children and adolescents with T1DM. Moreover, association of miR-34a with markers of dyslipidemia and endothelial dysfunction was identified, suggesting that it could play a role in regulation of lipid metabolism and endothelial function in T1DM.
No takes yet. Share an insight, caveat, or question.
Ibrahim et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: